1. Home
  2. FSV vs CORT Comparison

FSV vs CORT Comparison

Compare FSV & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FirstService Corporation

FSV

FirstService Corporation

HOLD

Current Price

$138.15

Market Cap

5.9B

Sector

Finance

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$116.76

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSV
CORT
Founded
1988
1998
Country
Canada
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
9.7B
IPO Year
2015
2001

Fundamental Metrics

Financial Performance
Metric
FSV
CORT
Price
$138.15
$116.76
Analyst Decision
Buy
Buy
Analyst Count
10
5
Target Price
★ $173.25
$141.00
AVG Volume (30 Days)
122.8K
★ 694.3K
Earning Date
10-22-2026
11-03-2026
Dividend Yield
★ 0.91%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.09
Revenue
N/A
★ $761,407,000.00
Revenue This Year
$4.18
$50.53
Revenue Next Year
$5.81
$48.90
P/E Ratio
★ $49.49
$1,251.72
Revenue Growth
N/A
★ 12.79
52 Week Low
$119.41
$28.66
52 Week High
$189.05
$126.38

Technical Indicators

Market Signals
Indicator
FSV
CORT
Relative Strength Index (RSI) 52.22 45.31
Support Level $124.04 $108.33
Resistance Level $146.14 $122.96
Average True Range (ATR) 2.45 4.61
MACD 1.10 -0.97
Stochastic Oscillator 66.22 32.39

Price Performance

Historical Comparison
FSV
CORT

About FSV FirstService Corporation

FirstService Corp is engaged in outsourcing property services. The company operates in two business divisions: FirstService Residential and FirstService Brands. FirstService Residential has service contracts to manage thousands of residential communities, including high and low-rise condominiums and co-operatives. FirstService Brands generates the majority of the company's revenue and provides property services to residential and commercial customers through the following brands: California Closets; Paul Davis Restoration; CertaPro Painters, Floor Coverings International, and Pillar to Post Home Inspectors. The company earns the majority of its revenue in the United States, with the remaining revenue generated in Canada.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: